Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2018-06-01 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于公司获得《药品GMP证书》的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a pharmaceutical GMP certificate from a regulatory authority. It is a formal disclosure about a certification achievement, not a financial report, management change, or shareholder meeting material. The document is short (573 characters) and serves as a regulatory announcement about compliance and certification. It does not contain financial data, earnings information, or meeting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-06-01 Chinese
关于控股股东、实际控制人之一减持股份的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the reduction of shares held by a controlling shareholder and actual controller of the company. It details the number of shares sold, the method of sale, the shareholding percentages before and after the sale, and compliance with relevant laws and commitments. There is no financial data, earnings information, or report content. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2018-05-25 Chinese
关于可转换公司债券2018年跟踪信用评级报告的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a credit rating report for a convertible bond issued by the company. It references the issuance of a credit rating report by a rating agency and provides a link to the full report on an external website. The document itself does not contain the full credit rating report or detailed financial data but rather announces the existence and summary of the rating. The document length is short (812 characters), and it states that the detailed report can be found elsewhere, indicating it is an announcement rather than the report itself. This fits the criteria for a Regulatory Filings (RNS) category, which covers general regulatory announcements and miscellaneous filings that do not fit other specific categories.
2018-05-16 Chinese
可转换公司债券2018年跟踪信用评级报告
Regulatory Filings
2018-05-16 Chinese
2018年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "2018年第一季度报告" which translates to "2018 First Quarter Report." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and management commentary on financial performance for the first quarter of 2018. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2018
2018-04-27 Chinese
关于第三届监事会第十八次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolution passed by the Supervisory Board regarding the review of the company's 2018 first quarter report. It states that the Supervisory Board has audited and approved the procedures and contents of the quarterly report, confirming its accuracy and compliance. The document itself does not contain the actual financial statements or detailed financial data of the quarterly report but is a formal announcement of the Supervisory Board's approval of that report. The document length is short (698 characters), and it serves as a formal meeting resolution announcement rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a formal disclosure related to the quarterly report but not the report itself.
2018-04-27 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.